Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 22:01:07 - browse：463

Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Supreme Court strikes down use of affirmative action
Next article： Unique patient identifier: Experts argue the benefits, pitfalls

leisure time

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

A solution to the after

Alabama hospital puts IVF treatments on hold

Why palliative psychiatry is worth discussing

Devoted Health’s losses in Medicare Advantage persist

Obesity drugs seen as possible treatment for liver disease MASH

leisure time

Wikipedia

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

PBM reform efforts get punted in Congress

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD: Venture capital, Gilead, and more M&A

How to save PrEP access — and even expand it

Bernie brings in new pharma CEOs to talk drug prices

DIEP, the 'gold standard' of breast reconstruction, is under threat

Alabama hospital puts IVF treatments on hold

After affirmative action ruling, medical educators look to 'holistic review'

Global cancer cases to surge 77% by 2050, WHO report says

focus

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Alabama IVF ruling threatens families facing fatal genetic disease

Medicare inequities exacerbate Puerto Rico’s health disparities

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

focus

knowledge

leisure time

hotspot